IST:SURGY Income Statement

Financials in millions TRY. Fiscal year is January - December.

Millions TRY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Selling, General & Administrative	176.57	198.85	126.94	91.98
Other Operating Expenses	-469.47	3.04	1.85	-8.46
Total Operating Expenses	-292.9	201.9	128.78	83.53
Operating Income	292.9	-201.9	-128.78	-83.53
Interest Expense	-33.95	-1.09	-	-
Interest & Investment Income	-	114.12	-	-
Currency Exchange Gain (Loss)	-	0.36	-2.3	-0.15
Other Non-Operating Income	-619.9	-204.72	-47.55	-51.63
EBT Excluding Unusual Items	-360.96	-293.23	-178.63	-135.31
Gain (Loss) on Sale of Investments	-	175.76	12.76	-
Asset Writedown	-	909.18	1,478	747.19
Pretax Income	-360.96	791.71	1,313	611.88
Income Tax Expense	-1,338	462.95	-	-
Net Income	976.65	328.76	1,313	611.88
Net Income to Common	976.65	328.76	1,313	611.88
Net Income Growth	197.07%	-74.95%	114.51%	-
Basic Shares Outstanding	-	168	168	70
Diluted Shares Outstanding	-	168	168	70
Shares Change (YoY)	-	-	139.29%	-
EPS (Basic)	-	1.96	7.84	8.74
EPS (Diluted)	-	1.96	7.84	8.74
EPS Growth	-	-74.95%	-10.36%	-
EBITDA	295.09	-200.23	-128.13	-83.47
D&A For Ebitda	2.19	1.67	0.65	0.05
EBIT	292.9	-201.9	-128.78	-83.53
Effective Tax Rate	-	58.48%	-	-

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Real Estate template. Financial Sources.